149 related articles for article (PubMed ID: 22949365)
1. Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety.
Mao XH; Wang JY; Yan JL
J Zhejiang Univ Sci B; 2012 Sep; 13(9):745-50. PubMed ID: 22949365
[TBL] [Abstract][Full Text] [Related]
2. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.
Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X
Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472
[TBL] [Abstract][Full Text] [Related]
3. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars.
Qiu Y; Ma G; Lin X; Jin Y; Chen H; Hu X
Pediatr Dermatol; 2013; 30(3):342-7. PubMed ID: 23046440
[TBL] [Abstract][Full Text] [Related]
4. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
Ho NT; Lansang P; Pope E
J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
[TBL] [Abstract][Full Text] [Related]
6. Pyogenic granuloma in children: treatment with topical imiquimod.
Fallah H; Fischer G; Zagarella S
Australas J Dermatol; 2007 Nov; 48(4):217-20. PubMed ID: 17956478
[TBL] [Abstract][Full Text] [Related]
7. [Clinical application of imiquimod for the treatment of infantile hemangiomas].
Ma G; Lin XX; Jiang CH; Chen H; Li W; Hu XJ; Jin YB; Chen D; Chen XD; Ye XX
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):411-4. PubMed ID: 22292400
[TBL] [Abstract][Full Text] [Related]
8. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.
Welsh O; Olazarán Z; Gómez M; Salas J; Berman B
J Am Acad Dermatol; 2004 Oct; 51(4):639-42. PubMed ID: 15389206
[TBL] [Abstract][Full Text] [Related]
9. Pyogenic granuloma in ten children treated with topical imiquimod.
Tritton SM; Smith S; Wong LC; Zagarella S; Fischer G
Pediatr Dermatol; 2009; 26(3):269-72. PubMed ID: 19706086
[TBL] [Abstract][Full Text] [Related]
10. Two pediatric cases of pyogenic granuloma treated with imiquimod 5% cream: combined clinical and dermatoscopic evaluation and review of the literature.
Musumeci ML; Lacarrubba F; Anfuso R; Li Calzi M; Micali G
G Ital Dermatol Venereol; 2013 Feb; 148(1):147-52. PubMed ID: 23407084
[TBL] [Abstract][Full Text] [Related]
11. Involution of infantile haemangiomas after imiquimod 5% cream.
Barry RB; Hughes BR; Cook LJ
Clin Exp Dermatol; 2008 Jul; 33(4):446-9. PubMed ID: 18485022
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
13. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma.
McCuaig CC; Dubois J; Powell J; Belleville C; David M; Rousseau E; Gendron R; Jafarian F; Auger I
Pediatr Dermatol; 2009; 26(2):203-12. PubMed ID: 19419474
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of a therapy-resistant pyogenic granuloma with topical imiquimod 5% cream.
Goldenberg G; Krowchuk DP; Jorizzo JL
J Dermatolog Treat; 2006; 17(2):121-3. PubMed ID: 16766338
[TBL] [Abstract][Full Text] [Related]
15. Pyogenic granuloma: complete remission under occlusive imiquimod 5% cream.
Georgiou S; Monastirli A; Pasmatzi E; Tsambaos D
Clin Exp Dermatol; 2008 Jul; 33(4):454-6. PubMed ID: 18261135
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases.
Senchak AJ; Dann M; Cable B; Bessinger G
Ear Nose Throat J; 2010 Mar; 89(3):E21-5. PubMed ID: 20229466
[TBL] [Abstract][Full Text] [Related]
17. Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks.
Chang CJ; Hsiao YC; Mihm MC; Nelson JS
Lasers Surg Med; 2008 Nov; 40(9):605-10. PubMed ID: 18951427
[TBL] [Abstract][Full Text] [Related]
18. Pyogenic granuloma in two children successfully treated with imiquimod 5% cream.
Gencoglan G; Inanir I; Gündüz K
Pediatr Dermatol; 2009; 26(3):366-8. PubMed ID: 19706116
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
Bostanci S; Kocyigit P; Vural S; Heper AO; Botsali A
Dermatol Surg; 2018 Jan; 44(1):36-41. PubMed ID: 29016542
[TBL] [Abstract][Full Text] [Related]
20. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
Micali G; De Pasquale R; Caltabiano R; Impallomeni R; Lacarrubba F
J Dermatolog Treat; 2002 Sep; 13(3):123-7. PubMed ID: 12227875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
